A Comparative Study of the Respiratory Neonatal Outcomes Utilizing Dexamethasone Sodium Phosphate versus a Mixture of Betamethasone Dipropionate and Betamethasone Sodium Phosphate as an Antenatal Corticosteroid Therapy (original) (raw)

Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants

Giuseppe Del Vento

Intensive Care Medicine, 1999

View PDFchevron_right

Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy

Yuh-jyh Lin

Pediatric Pulmonology, 1999

View PDFchevron_right

A case-control study on the effects of incomplete, one, and more than one dexamethasone course on acute respiratory problems in preterm neonates born between 280 and 366 weeks of gestation

Saifon Chawanpaiboon

BMC Pregnancy and Childbirth

View PDFchevron_right

Does the Use of Antenatal Corticosteroids Reduce Respiratory Morbidity in Babies Born in Late Preterm Period?

fatimat akinlusi

Research Square (Research Square), 2023

View PDFchevron_right

Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth

Philippa Middleton

Cochrane Database of Systematic Reviews, 2007

View PDFchevron_right

Temporal trends of the use of dexamethasone for the treatment of bronchopulmonary dysplasia in very low-birth- weight preterm infants: a single-center evaluation

Journal einstein (São Paulo)

einstein (São Paulo), 2024

View PDFchevron_right

Effects of Antenatal Dexamethasone on Respiratory Distress in Late Preterm Infant: a randomized controlled trial

nipawan attawattanakul

Thai Journal of Obstetrics and Gynaecology, 2015

View PDFchevron_right

Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study

Tsu F Yeh

PEDIATRICS, 1998

View PDFchevron_right

Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled Trials

Martin Offringa

Pediatrics, 2009

View PDFchevron_right

Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm

Janet Peacock

PloS one, 2017

View PDFchevron_right

A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity

David Odd

Journal of Paediatrics and Child Health, 2004

View PDFchevron_right

Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants

Barbara Mettelman

The Journal of Pediatrics, 2019

View PDFchevron_right

Effectiveness of Antenatal Dexamethasone in Reducing Respiratory Distress Syndrome and Mortality in Preterm Neonates: a Nested Case Control Study

Ritah F Mutagonda

View PDFchevron_right

Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome

Shraga Blazer

Archives of Disease in Childhood - Fetal and Neonatal Edition, 1996

View PDFchevron_right

Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome

TF Fok, Myrna Dolovich

Archives of Disease in …, 1999

View PDFchevron_right

The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: A two-year follow-up study

Wen-hui Tsai

Acta Paediatrica, 2005

View PDFchevron_right

Effect of Antenatal Dexamethasone on Respiratory Distress in Late Preterm Infants: Results from the First Vietnamese Matched Cohort Study

Minh Tam Le

2021

View PDFchevron_right

Relationship of Time Interval between Antenatal Corticosteroid Administrations to Delivery with Respiratory Distress in Preterm Newborns

lavanya rai

International Journal of Infertility & Fetal Medicine, 2015

View PDFchevron_right

Neurodevelopmental Sequelae in Preterm Infants at Risk for Chronic Lung Effects of Higher Versus Lower Dexamethasone Doses on Pulmonary and

Wes Onland

2000

View PDFchevron_right

European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants – 2010 Update

Komang Purnamaningsih

Neonatology, 2010

View PDFchevron_right

Effects of Higher Versus Lower Dexamethasone Doses on Pulmonary and Neurodevelopmental Sequelae in Preterm Infants at Risk for Chronic Lung Disease: A Meta-analysis

Wes Onland

PEDIATRICS, 2008

View PDFchevron_right

Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial

Melania Amorim

BMJ, 2011

View PDFchevron_right

Postnatal Corticosteroid to Prevent or Treat Chronic Lung Disease in Preterm Infants

suma pyati

2010

View PDFchevron_right

Update on prenatal steroid for prevention of respiratory distress

Glen Aylward

American Journal of Obstetrics and Gynecology, 1986

View PDFchevron_right

Antenatal use of Corticosteroids to Prevent Respiratory Insufficiency in Preterm Babies

M S SREELAKSHMI

Asian Journal of Pharmaceutical Education and Research, 2020

View PDFchevron_right

European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants - 2013 Update

Ola Saugstad

Neonatology, 2013

View PDFchevron_right

Antenatal dexamethasone use and respiratory distress in late preterm infants: results from first Vietnamese matched cohort study

Vu Quoc Huy Nguyen

BMC Pregnancy and Childbirth

View PDFchevron_right